TFOS Lifestyle: Impact of elective medications and procedures on the ocular surface

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

David Moher, A. Liberati, Jennifer Tetzlaff et al. · BMJ · 2009 · 83.3K citations · Full text

Public Health, Biostatistics, Evidence-based Practice +11

ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions

Jonathan A C Sterne, Miguel A. Hernán, Barnaby C Reeves et al. · BMJ · 2016 · 19K citations · Full text

Public Health, Biostatistics, Health Services Research +15

The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses

George A. Wells · Medical Entomology and Zoology · 2014 · 17.9K citations · Full text

Public Health, Biostatistics, Clinical Epidemiology +9

AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both

Beverley Shea, Barnaby C Reeves, George A. Wells et al. · BMJ · 2017 · 10.4K citations · Full text

Public Affairs, Health Policy, Evidence-based Practice +16

Riboflavin/ultraviolet-a–induced collagen crosslinking for the treatment of keratoconus

Gregor Wollensak, Eberhard Spoerl, Theo Seiler · American Journal of Ophthalmology · 2003 · 2.9K citations

Medicine, Dermatology, Ophthalmology +12